Data / Drug companies / Esomeprazole magnesium
Esomeprazole magnesium: 77 companies and 190 products in the FDA NDC directory
Esomeprazole magnesium is listed in the FDA National Drug Code Directory by 77 companies, with 190 products in commercial distribution. 179 of the products (94.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, delayed release; granule, delayed release; tablet, delayed release, and the newest product started marketing on October 16, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 77
- Products
- 190
- Generic (ANDA) products
- 179 (94.2%)
- Application numbers
- 40
- Routes
- Oral
- Brand names
- Esomeprazole, Nexium, Nexium 24HR, Acid Reducer, Nexium 24HR ClearMinis
- openFDA record search
- api.fda.gov
Companies that list esomeprazole magnesium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 12 | capsule, delayed release; capsule, delayed release pellets | Generic drugs (ANDA) | November 20, 2023 |
| Bryant Ranch Prepack | 11 | capsule, delayed release; capsule, delayed release pellets | Generic drugs (ANDA) | October 18, 2023 |
| Dr. Reddy's Laboratories Inc. | 8 | capsule, delayed release; tablet, delayed release | Generic drugs (ANDA) | March 1, 2025 |
| AstraZeneca Pharmaceuticals LP | 7 | granule, delayed release; capsule, delayed release | New drug applications (NDA) | June 1, 2012 |
| Walgreen Company | 7 | capsule, delayed release; tablet, delayed release | Generic drugs (ANDA) | June 20, 2025 |
| Aurobindo Pharma Limited | 6 | granule, delayed release; capsule, delayed release | Generic drugs (ANDA) | April 15, 2025 |
| Aurohealth LLC | 6 | capsule, delayed release; tablet, delayed release | Generic drugs (ANDA) | November 14, 2025 |
| Advanced Rx of Tennessee, LLC | 5 | capsule, delayed release | Generic drugs (ANDA) | October 29, 2024 |
| Cipla USA Inc. | 5 | for suspension; granule, for suspension, extended release | Generic drugs (ANDA) | January 7, 2025 |
| Torrent Pharmaceuticals Limited | 5 | granule, delayed release | Generic drugs (ANDA) | March 5, 2025 |
| Preferred Pharmaceuticals Inc. | 4 | capsule, delayed release | Generic drugs (ANDA) | September 5, 2025 |
| Zydus Lifesciences Limited | 4 | granule, delayed release; capsule, delayed release | Generic drugs (ANDA) | June 30, 2023 |
| Zydus Pharmaceuticals USA Inc. | 4 | capsule, delayed release; granule, delayed release | Generic drugs (ANDA) | June 30, 2023 |
| CVS Pharmacy | 3 | capsule, delayed release; tablet, delayed release | Generic drugs (ANDA) | December 31, 2021 |
| CVS Woonsocket Prescription Center, Incorporated | 3 | tablet, delayed release; capsule, delayed release | Generic drugs (ANDA) | August 30, 2025 |
| Cardinal Health 110, LLC. DBA Leader | 3 | capsule, delayed release; tablet, delayed release | Generic drugs (ANDA) | October 3, 2025 |
| H E B | 3 | capsule, delayed release | Generic drugs (ANDA) | July 1, 2026 |
| Haleon US Holdings LLC | 3 | capsule, delayed release; tablet | New drug applications (NDA) | March 1, 2017 |
| NuCare Pharmaceuticals,Inc. | 3 | capsule, delayed release | Generic drugs (ANDA) | March 19, 2021 |
| Remedyrepack Inc. | 3 | capsule, delayed release | Generic drugs (ANDA) | October 16, 2026 |
| Rising Pharma Holdings, Inc. | 3 | capsule, delayed release | Generic drugs (ANDA) | May 30, 2026 |
| Safeway | 3 | capsule, delayed release | Generic drugs (ANDA) | April 29, 2024 |
| Amerisource Bergen | 2 | capsule, delayed release | Generic drugs (ANDA) | August 30, 2025 |
| Ascend Laboratories, LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | October 20, 2017 |
| Asclemed USA, Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | June 2, 2020 |
| Aurobindo Pharma Limited | 2 | capsule, delayed release | Generic drugs (ANDA) | April 21, 2016 |
| Biocon Pharma Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | March 19, 2021 |
| Camber Pharmaceuticals, Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | June 2, 2020 |
| Chain Drug Marketing Association, Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | October 9, 2026 |
| Discount Drug Mart | 2 | capsule, delayed release | Generic drugs (ANDA) | March 1, 2025 |
| Glenmark Therapeutics Inc., USA | 2 | capsule, delayed release | Generic drugs (ANDA) | August 22, 2023 |
| Golden State Medical Supply, Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | April 30, 2018 |
| Granules Pharmaceuticals Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | October 18, 2023 |
| Innovus Pharmaceuticals, Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | May 25, 2023 |
| Kroger Company | 2 | capsule, delayed release | Generic drugs (ANDA) | March 1, 2025 |
| Lannett Company, Inc. | 2 | capsule, delayed release pellets | Generic drugs (ANDA) | September 1, 2017 |
| Mylan Pharmaceuticals Inc. | 2 | capsule, delayed release pellets | Generic drugs (ANDA) | August 3, 2015 |
| NorthStar Rx LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | September 17, 2019 |
| PD-Rx Pharmaceuticals, Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | April 21, 2016 |
| Quallent Pharmaceuticals Health LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | December 1, 2022 |
| Solco Healthcare US, LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | March 28, 2023 |
| Somerset Therapeutics, LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | August 15, 2023 |
| Sun Pharmaceutical Industries, Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | September 18, 2025 |
| Valu Merchandisers Company | 2 | capsule, delayed release | Generic drugs (ANDA) | August 14, 2020 |
| Yyba Corp | 2 | capsule; capsule, delayed release | Generic drugs (ANDA) | April 1, 2026 |
| Zhejiang Yongtai Pharmaceutical Co., Ltd | 2 | capsule, delayed release | Generic drugs (ANDA) | January 9, 2025 |
| Ahold U.S.A., Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | October 16, 2017 |
| American Health Packaging | 1 | capsule, delayed release | Generic drugs (ANDA) | August 19, 2026 |
| AvPAK | 1 | capsule, delayed release | Generic drugs (ANDA) | March 23, 2026 |
| Camber Consumer Care Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | June 2, 2020 |
| Chain Drug Marketing Association | 1 | capsule, delayed release | Generic drugs (ANDA) | July 6, 2018 |
| Direct_Rx | 1 | capsule, delayed release | Generic drugs (ANDA) | January 19, 2022 |
| Dr. Reddy's Laboratories Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | December 30, 2023 |
| Family Dollar (family Wellness) | 1 | capsule, delayed release | Generic drugs (ANDA) | August 17, 2023 |
| Geri-Care Pharmaceuticals, Corp | 1 | capsule, delayed release | Generic drugs (ANDA) | August 19, 2026 |
| Grocery Outlet, Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | June 5, 2026 |
| Guardian Drug Company | 1 | capsule, delayed release | Generic drugs (ANDA) | March 24, 2023 |
| Harris Teeter | 1 | tablet | Generic drugs (ANDA) | March 3, 2021 |
| Little Pharma, Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | March 23, 2021 |
| Major Pharmaceuticals | 1 | capsule, delayed release | Generic drugs (ANDA) | December 10, 2015 |
| Medsource Pharmaceuticals | 1 | capsule, delayed release | Generic drugs (ANDA) | December 10, 2015 |
| Meijer Distribution Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | March 17, 2020 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | capsule, delayed release | Generic drugs (ANDA) | November 20, 2023 |
| Ohm Laboratories Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | August 14, 2020 |
| Proficient Rx LP | 1 | capsule, delayed release | Generic drugs (ANDA) | March 19, 2021 |
| Proficient Rx LP | 1 | capsule, delayed release | Generic drugs (ANDA) | December 10, 2015 |
| Proficient Rx LP | 1 | capsule, delayed release | Generic drugs (ANDA) | December 10, 2015 |
| Publix Super Markets Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | March 30, 2020 |
| Reliable 1 Laboratories LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | April 14, 2023 |
| Retail Business Services, LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | October 16, 2017 |
| Rising Pharma Holdings, Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | December 1, 2022 |
| St. Mary's Medical Park Pharmacy | 1 | capsule, delayed release | Generic drugs (ANDA) | September 17, 2026 |
| Target Corporation | 1 | capsule, delayed release | Generic drugs (ANDA) | March 13, 2020 |
| Time Cap Laboratories, Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | November 14, 2023 |
| Topco Associates LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | March 12, 2020 |
| Wal-Mart Stores Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | October 16, 2017 |
| Walmart Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | September 20, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, delayed release | 147 | 77.4% |
| Granule, delayed release | 18 | 9.5% |
| Tablet, delayed release | 9 | 4.7% |
| Capsule, delayed release pellets | 7 | 3.7% |
| For suspension | 4 | 2.1% |
| Tablet | 3 | 1.6% |
| Capsule | 1 | 0.5% |
| Granule, for suspension, extended release | 1 | 0.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 179 | 94.2% |
| New drug applications (NDA) | 11 | 5.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Proton Pump Inhibitor | 190 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.